O’Brien, S. “Minimal Residual Disease Elimination by Consolidation Therapy With Alemtuzumab”. Hematology Meeting Reports (formerly Haematologica Reports), vol. 1, no. 2, May 2009, doi:10.4081/hmr.v1i2.227.